A focus on stroke at the start of the century transformed treatments and improved outcomes, but pressure on the NHS has seen those advances stymied. Emma Wilkinson looks for a reboot A boost to stroke ...

Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.

Hyderabad: Apollo Hospitals organised the STAT-2025 Conference on Stroke Thrombolysis and Thrombectomy with leading ...

NHS pressures and “deep inequalities in care” are “failing” stroke patients, according to a report. The Stroke Association ...

She hopes speaking out ahead of International Women’s Day will help inspire other young stroke survivors to keep fighting on ...

High-risk acute pulmonary embolism affects around 5% of all pulmonary embolisms and can take a dramatic course even in young ...

A current study involving the University Hospital Bonn (UKB) has investigated which treatment strategy offers the best ...

The approval is based on results of the AcT trial, where tenecteplase was comparable to alteplase for safety and efficacy.

FDA approval was based on the AcT noninferiority trial that found tenecteplase (at 0.25 mg/kg) to be at least on par with alteplase for safety and efficacy in acute ischemic stroke in Canadians ...

The thrombectomy approach was chosen at the operator’s discretion, mostly consisting of stent-retrievers from a variety of manufacturers. Although the trial reported a successful reperfusion rate ...